摘要
调钙素(RGN)是一种多功能蛋白质,它最初被称为钙离子(Ca2+)结合蛋白,在维持细胞内钙离子浓度中起着相关作用。然而,因为随着衰老而表达下调,RGN也被称为衰老标记蛋白-30。RGN蛋白是X染色体基因的产物,其转录是由多种激素和非激素因子调控。除了在Ca2+动态平衡中众所周知的作用外,RGN也与许多细胞内信号通道的控制,基本的生物过程如氧化应激、细胞增殖、凋亡和代谢有关。RGN通过减少活性氧生成和增强抗氧化防御系统,已经展示出了抗氧化作用。RGN的抑制细胞增殖的作用与致癌基因和肿瘤抑制基因表达的调控有关。结果清楚地显示现有知识表明RGN在主要生物过程的控制实际上被公认为癌症的检验印记。不仅如此,它显示出肿瘤的发生和发展是由RGN失表达而支撑,而在RGN过度表达是针对化学诱导的肿瘤发生的保护作用。本文综述了在RGN组织表达中调控的机制并讨论了表明RGN作为一种新的肿瘤抑制蛋白的实验证据。
关键词: 调钙素,癌症,肿瘤抑制,SMP30,细胞增殖,凋亡,代谢,氧化应激。
Current Molecular Medicine
Title:The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views
Volume: 16 Issue: 7
Author(s): C. V. Vaz, S. Correia, H. J. Cardoso, M. I. Figueira, R. Marques, C. J. Maia, S. Socorro
Affiliation:
关键词: 调钙素,癌症,肿瘤抑制,SMP30,细胞增殖,凋亡,代谢,氧化应激。
摘要: Regucalcin (RGN) is a multifunctional protein that was first described as a calcium (Ca2+)-binding protein playing a relevant role in the maintenance of intracellular Ca2+ concentration. However, due to its downregulated expression with aging, RGN is also known as senescence marker protein-30. The RGN protein is an X-chromosome gene product, whose transcription is regulated by a myriad of hormonal and non-hormonal factors. Besides the well-known role in Ca2+ homeostasis, RGN has also been linked to the control of several intracellular signaling pathways, and basic biological processes, such as oxidative stress, cell proliferation, apoptosis, and metabolism. RGN has been shown to have antioxidant properties by its activity reducing the production of reactive oxygen species and increasing the antioxidant defenses. The role of RGN suppressing cell proliferation is associated with the regulation of expression of oncogenes and tumor suppressor genes. It results clear that all the existent knowledge implicates RGN in the control of the main biological processes actually recognized as the hallmarks of cancer. Moreover, it has been shown that tumor onset and progression are underpinned by the loss of RGN expression, whereas RGN overexpression showed to have a protective role against the development of chemicallyinduced tumors. This review describes the mechanisms that control the tissue expression of RGN and discusses the experimental evidence that indicate RGN as a new tumor suppressor protein.
Export Options
About this article
Cite this article as:
C. V. Vaz, S. Correia, H. J. Cardoso, M. I. Figueira, R. Marques, C. J. Maia, S. Socorro , The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views, Current Molecular Medicine 2016; 16 (7) . https://dx.doi.org/10.2174/1566524016666160714124550
DOI https://dx.doi.org/10.2174/1566524016666160714124550 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers